BioMarin Pharmaceutical | BMRN - Employees Total Number

Stock Price
56.10
Daily Change
-1.67 -2.89%
Monthly
-1.23%
Yearly
-33.48%
Q3 Forecast
57.29

BioMarin Pharmaceutical reported 3.04K in Employees for its fiscal year ending in December of 2024.



Financials
Stock Price USD
Assets USD 7.46B
Cash and Equivalent USD 1.21B
Cost of Sales USD 154.94M
Current Assets USD 3.81B
Current Liabilities USD 684.25M
Debt USD 603.87M
EBIT USD 276.89M
EBITDA USD 295.45M
Employees 3.04K
EPS Earnings Per Share USD 1.44
Equity Capital and Reserves USD 6.03B
Gross Profit on Sales USD 670.47M
Interest Expense on Debt USD 2.68M
Interest Income USD 18.83M
Loan Capital USD 596.16M
Market Capitalization USD 10.75B
Net Income USD 240.53M
Operating Expenses USD 548.52M
Operating Profit USD 276.89M
Ordinary Share Capital USD 192M
PE Price to Earnings USD 15.13
Pre-Tax Profit USD 297.87M
Sales Revenues USD 825M
Selling and Administration Expenses USD 232.28M
Stock USD 1.34B
Trade Creditors USD 684.25M
Trade Debtors USD 855.86M

Employees Change Date
Acadia Pharmaceuticals 597 86 Dec/2023
Agios Pharmaceuticals 486 103 Dec/2024
Alnylam Pharmaceuticals 2.23K 130 Dec/2024
Amgen 28K 1.3K Dec/2024
Bayer 99.72K 1.65K Dec/2023
Biogen 7.6K 35 Dec/2024
BioMarin Pharmaceutical 3.04K 361 Dec/2024
Gilead Sciences 17.6K 400 Dec/2024
Incyte 2.62K 93 Dec/2024
Insmed 1.27K 359 Dec/2024
Ionis Pharmaceuticals 1.07K 142 Dec/2024
Moderna 5.8K 200 Dec/2024
Neurocrine Biosciences 1.8K 400 Dec/2024
PTC Therapeutics 939 49 Dec/2024
Roche Holding 103.61K 2.69K Dec/2022
Sanofi EUR 91.57K 3.87K Dec/2022
Sarepta Therapeutics 1.37K 58 Dec/2024
Ultragenyx Pharmaceutical 1.29K 18 Dec/2024
United Therapeutics 1.3K 137 Dec/2024
Vertex Pharmaceuticals 6.1K 700 Dec/2024